Concepedia

Kelly D. Lengyel

KD

Statistics

Publications

2

Citations

51

H-Index

2

Active since

2008

Affiliations

Bristol-Myers Squibb (United States)(Current)

Kelly D. Lengyel is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, pharmacotherapy, and neuropharmacology.

Top concepts

Publications per year

2008–2012

2

Publications

2

Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: Methodology and biological significance

Kelly D. Lengyel, Rick L. Pieschl, Todd Strong et al. · Neuropharmacology · 2008 · 40 citations

, , +10

Design, optimization, and in vivo evaluation of a series of pyridine derivatives with dual NK1 antagonism and SERT inhibition for the treatment of depression

Kevin W. Gillman, Michael F. Parker, Mark Silva et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 11 citations · Full text

, , +10

1–2 of 2